Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Respiratory Distress”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT03368092
What this trial is testing

Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma

Who this might be right for
Multiple TraumaRespiratory Distress Syndrome, Adult
University Hospital, Strasbourg, France 500
Not applicableWithdrawnNCT00172263
What this trial is testing

The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes

Who this might be right for
Severe Acute Respiratory Syndrome
National Taiwan University Hospital
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Testing effectiveness (Phase 2)Study completedNCT04745442
What this trial is testing

Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19

Who this might be right for
Covid19Severe Acute Respiratory SyndromeDistress Respiratory Syndrome
Maimónides Biomedical Research Institute of Córdoba 48
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Not applicableStudy completedNCT04751643
What this trial is testing

Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections

Who this might be right for
Intensive Care UnitsARDS, HumanCovid19
Hospices Civils de Lyon 21
Testing effectiveness (Phase 2)Study completedNCT04625738
What this trial is testing

Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome

Who this might be right for
COVID19 ARDS
Central Hospital, Nancy, France 30
Testing effectiveness (Phase 2)Ended earlyNCT04565249
What this trial is testing

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeSARS-CoV-2
Pliant Therapeutics, Inc. 6
Post-approval studies (Phase 4)Ended earlyNCT04335786
What this trial is testing

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Who this might be right for
Acute Respiratory Distress SyndromeSARS-CoV-2COVID+2 more
Radboud University Medical Center 23
Not applicableStudy completedNCT02814994
What this trial is testing

Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients

Who this might be right for
Respiratory FailureAcute Respiratory Distress Syndrome
Southeast University, China 242
Not applicableUnknownNCT04497454
What this trial is testing

Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Respiratory Distress SyndromeMechanical VentilationSARS (Severe Acute Respiratory Syndrome)
University of Sao Paulo General Hospital 128
Large-scale testing (Phase 3)Ended earlyNCT05531149
What this trial is testing

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Who this might be right for
Respiratory InfectionPneumoniaCommunity-acquired Pneumonia+5 more
Biotest 107
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Not applicableNot Yet RecruitingNCT07315815
What this trial is testing

Physiological Effects of Controlled vs. Assisted Ventilation During Moderate-to-severe ARDS (PEARL Study)

Who this might be right for
Ventilator-Induced Lung Injury
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Testing effectiveness (Phase 2)Ended earlyNCT04511650
What this trial is testing

Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019

Who this might be right for
COVID-19Acute Respiratory Distress Syndrome (ARDS)
EyePoint Pharmaceuticals, Inc. 31
Not applicableStudy completedNCT07803614
What this trial is testing

Pressure Release Ventilation Compared to Lung Protective Ventilation in Moderate and Severe ARDS

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
Koot Ahmad 60
Large-scale testing (Phase 3)Study completedNCT06729606
What this trial is testing

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 471
Testing effectiveness (Phase 2)UnknownNCT04331613
What this trial is testing

Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeVirus; Pneumonia+1 more
Chinese Academy of Sciences 9
Not applicableStudy completedNCT07466524
What this trial is testing

SuPAR Michigan M2C2 Heterogeneity Validation Cohort Study

Who this might be right for
COVID-19Severe Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
ViroGates A/S 367
Next Page